New Patient Education Resources From NCCN Empower Patients Along with Chronic Lymphocytic Leukemia and Hodgkin Lymphoma to Job Alongside Their Physicians to Make Informed Decisions Regarding Their Treatment
FORT WASHINGTON, PA–(Marketwired – March 03, 2016) – To further educate people Along with Chronic Lymphocytic Leukemia (CLL) and Hodgkin Lymphoma Regarding the many efficient treatment choices for their disease, the National Comprehensive Cancer Network® (NCCN®) has actually published the NCCN Guidelines for Patients® and NCCN Quick Guide™ collection for CLL and Hodgkin Lymphoma, the newest additions to NCCN’s library of patient education resources. NCCN has actually likewise published NCCN Quick Guides™ to complement the current edition of the NCCN Guidelines for Patients®: Chronic Myelogenous Leukemia (CML).
CLL is the many prevalent adult leukemia in Western countries[i], and it is estimated that, in 2016, a lot more compared to 18,000 people will certainly be diagnosed Along with CLL in the United States[ii].
The NCCN Guidelines for Patients®: CLL is the very first in a collection of resources dedicated to patient education for Non-Hodgkin’s Lymphomas; subsequent resources outlining treatment choices for Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Mycosis Fungoides, and Peripheral T-Cell Lymphoma will certainly be published this year.
Because of clinical advances over the past 3 decades, Hodgkin Lymphoma, even though rare, is curable in at the very least 80 percent of patients Along with five-year survival rates that are unmatched in any sort of others cancer.[iii]
The NCCN Guidelines for Patients and NCCN Quick Guide™ collection for Hodgkin Lymphoma have actually been broken out in to 3 distinct sections to give users Along with post many pertinent to their diagnosis: Treatment Overview, Classical Hodgkin Lymphoma, and Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Made offered through support of the NCCN Foundation®, the NCCN Guidelines for Patients and NCCN Quick Guide™ collection for CLL, CML, and Hodgkin Lymphoma are offered to download without charge on NCCN.org/patients; for post Regarding print copies, visit NCCN.org/patients.
“Through providing free resources for people Along with these blood cancers, NCCN Foundation strives to empower patients by providing suggestions in to their treatment options, allowing them to Job alongside their care group to make informed decision Regarding their care,” said Marcie R. Reeder, MPH, Executive Director, NCCN Foundation.
The NCCN Guidelines for Patients, translations of the NCCN Clinical Technique Guidelines in Oncology (NCCN Guidelines®), are created to give people Along with cancer and their caregivers Along with state-of-the-art treatment post in easy-to-already know language. The NCCN Guidelines® are produced by multidisciplinary panels of experts from NCCN Member Institutions and feature algorithms that treat correct management choices from first work-up through the road of the disease.
NCCN Guidelines for Patients and NCCN Quick Guide™ series, abbreviated references outlining crucial points of the NCCN Guidelines for Patients, are written according to plain language principles to increase good health literacy, and the design and format feature patient-friendly elements, such as medical illustrations of anatomy, tests, and treatments. These resources likewise feature an expansive glossary of terms and acronyms. The NCCN Guidelines for Patients and the NCCN Quick Guide™ collection do not replace the expertise and clinical judgment of the physician.
NCCN currently offers NCCN Guidelines for Patients for the following: Breast, Colon, Esophageal, Kidney, Non-Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers; Acute Lymphoblastic Leukemia; Caring for Adolescents and Young Adults (AYA); Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkin Lymphoma; Lung Cancer Screening, Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; and Soft Tissue Sarcoma.
To download or order the NCCN Guidelines for Patients and NCCN Quick Guide™ collection for CLL or Hodgkin Lymphoma, visit NCCN.org/patients.
About NCCN Foundation
Through philanthropy, the NCCN Foundation® empowers people through knowledge and advances the mission of NCCN to increase the quality, effectiveness, and efficiency of cancer care, so that patients Can easily live much better lives.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 2six of the nation’s leading cancer centers devoted to patient care, research, and education, is dedicated to enhancing the quality, effectiveness, and efficiency of cancer care so that patients Can easily live much better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present practical post to the lots of stakeholders in the good health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of producing clinical Technique guidelines correct for usage by patients, clinicians, and others good health care decision-makers.
The NCCN Member Institutions are: Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer focus and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Chance Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer focus | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Hunt Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer focus at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer focus of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, Brand-new York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer focus – James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer focus at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee good health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, Brand-new Haven, CT.
Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.org/patients.
[i] “NCCN Guidelines for Non-Hodgkin Lymphomas, V 2.2016.” NCCN.org. National Comprehensive Cancer Network, 17 Feb. 2016. Web. 22 Feb. 2016
[ii] “Cancer Facts & Figures 2016.” American Cancer Society. Web. 22 Feb. 2016.
[iii] “NCCN Guidelines for Hodgkin Lymphoma, V 2.2015.” NCCN.org. National Comprehensive Cancer Network, twenty Apr. 2015. Web. 8 Dec. 2015.
The adhering to files are offered for download:
